Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players - PowerPoint PPT Presentation

About This Presentation
Title:

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

Description:

Bharat Book Presents"Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players" provides in-depth analysis of the key therapeutic indications of oncology, breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL), with forecasts until 2018. It also looks at treatment usage patterns and includes insights into the oncology R&D pipeline. – PowerPoint PPT presentation

Number of Views:1086
Slides: 8
Provided by: bharatbookseo
Category:

less

Transcript and Presenter's Notes

Title: Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players


1
Oncology Therapeutics Market in India to
2018  
  • Bharat Book Bureau

2
Summary
  • "Oncology Therapeutics Market in India to 2018 -
    Introduction of Market-Based Pricing to Fuel
    Price Wars and Intense Competition Among Domestic
    and Multinational Players", which provides
    in-depth analysis of the key therapeutic
    indications of oncology, breast cancer,
    colorectal cancer, prostate cancer, lung cancer
    and Non-Hodgkins Lymphoma (NHL), with forecasts
    until 2018. It also looks at treatment usage
    patterns and includes insights into the oncology
    RD pipeline.

3
Continue
  • The Indian oncology therapeutics market for
    breast cancer, lung cancer, colorectal cancer,
    prostate cancer and NHL was estimated to be worth
    153.3m in 2011, having grown at a Compound
    Annual Growth Rate (CAGR) of 12.7 from 2004. It
    is expected to reach 238.8m in 2018 at a CAGR of
    6.5 from 2011. The slower growth in the forecast
    period is mainly due to the reduction in the
    price of leading marketed products for breast
    cancer, colorectal cancer, lung cancer and NHL
    after all 348 drugs on the National List of
    Essential Medicines (NLEM) are brought under
    price control regulations.The limitations of
    the current market are unclear patent laws,
    restrictive pricing and reimbursement policies,
    ailing infrastructure, and insufficient
    government aid. Low patient affordability is also
    a major restraint, and one that reimbursement and
    insurance policies must address if the market is
    to develop in the future.

4
Continue
  • Scope- The report analyzes treatment
    usage patterns, market characterization, pipeline
    analysis, competitive landscape and key MA
    trends in the breast cancer, colorectal cancer,
    prostate cancer, lung cancer and NHL markets.-
    Data and analysis for the oncology therapeutics
    market in India- Annualized market data for the
    oncology therapeutics market in India from 2004
    to 2011, with forecasts to 2018- Key drivers and
    restraints that have had a significant impact on
    the market- The competitive landscape of the
    oncology therapeutics market in India- Key MA
    activities and licensing agreements that have
    taken place in the Indian oncology therapeutics
    market

5
Continue
  • Reasons to buyThe report will enhance your
    decision-making capability by allowing you to
    - - Align your product portfolio to the markets
    with high growth potential- Develop market-entry
    and market-expansion strategies by identifying
    the potential regions and therapeutic segments
    poised for strong growth- Devise a more
    effectively tailored country strategy through the
    understanding of key drivers and barriers in the
    oncology market- Develop key strategic
    initiatives by understanding the key focus areas
    and leading companies- Accelerate and strengthen
    your market position by identifying key companies
    for mergers, acquisitions and strategic
    partnerships

6
Table Of Contents
  • 1 Table of Contents1 Table of Contents
    61.1 List of Tables 81.2 List of Figures 102
    Oncology Therapeutics Market in India
    Introduction 113 Oncology Therapeutics Market in
    India Market Overview 123.1 Population
    Dynamics 123.2 Cancer Registration Background in
    India 133.3 Most Common Cancers in India 143.4
    Cancer Mortality Rate 153.5 Market
    Characterization and Forecasts 163.6 Annual Cost
    of Therapy 183.7 Treatment Usage Pattern
    193.7.1 Diseased Population 203.7.2
    Prescription Population 20

7
For More Information You Can Visit-
  • http//www.bharatbook.com/healthcare-market-
    research-reports/oncology-therapeutics-market-in-i
    ndia-to-2018-introduction-of-market-based-pricing-
    to-fuel-price-wars-and-intense-competition-among-d
    omestic-and-multinational-players.html
  • Or visit us at
  • Bharat
    Book Bureau
    Phone 91 22 27810772, 27810773
    Fax 91 22 27812290
    Toll Free No for
    USA/Canada 1-866-279-8368
    E-mail info_at_bharatbook.com
    Website
    www.bharatbook.com
    Twitter https//twitter.com/BharatBook
    Blog
    http//www.bharatbook.com/market-reports-blog/
Write a Comment
User Comments (0)
About PowerShow.com